Page last updated: 2024-09-02

ecteinascidin 743 and Alloxan Diabetes

ecteinascidin 743 has been researched along with Alloxan Diabetes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cao, W; Deng, W; Hao, Q; Huang, Z; Li, J; Li, Q; Liu, D; Liu, Z; Su, R; Vadgama, J; Wang, K; Wang, P; Wu, K; Wu, Y	1

Other Studies

1 other study(ies) available for ecteinascidin 743 and Alloxan Diabetes

Article	Year
A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes-Associated Breast Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022, Volume: 9, Issue:6 Topics: Animals; Antineoplastic Agents, Alkylating; Breast Neoplasms; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Glucose; Glycolysis; Humans; Hypoglycemic Agents; Lactic Acid; Metformin; Mice; Monocarboxylic Acid Transporters; Muscle Proteins; Prognosis; Trabectedin	2022

Article

Year

A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes-Associated Breast Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022, Volume: 9, Issue:6

Topics: Animals; Antineoplastic Agents, Alkylating; Breast Neoplasms; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Glucose; Glycolysis; Humans; Hypoglycemic Agents; Lactic Acid; Metformin; Mice; Monocarboxylic Acid Transporters; Muscle Proteins; Prognosis; Trabectedin

2022